Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 18 | 18 | 18 | 18 | 18 |
| Cost of Goods | 21 | 21 | 21 | 2 | 2 |
| Gross Profit | -3 | -3 | -3 | 17 | 17 |
| Operating Expenses | 1,613 | 805 | 1,170 | 1,267 | 1,112 |
| Operating Income | -1,595 | -787 | -1,152 | -1,249 | -1,094 |
| Interest Expense | 3 | 33 | 1 | 2 | 2 |
| Other Income | -49 | -62 | 42 | 46 | 65 |
| Pre-tax Income | -1,647 | -882 | -1,110 | -1,204 | -1,031 |
| Net Income Continuous | -1,647 | -882 | -1,110 | -1,204 | -1,031 |
| Net Income | $-1,647 | $-882 | $-1,110 | $-1,204 | $-1,031 |
| EPS Basic Total Ops | -0.12 | 0.04 | -0.12 | -0.19 | -0.23 |
| EPS Basic Continuous Ops | -0.12 | 0.04 | -0.12 | -0.19 | -0.23 |
| EPS Diluted Total Ops | -0.12 | 0.04 | -0.12 | -0.19 | -0.23 |
| EPS Diluted Continuous Ops | -0.12 | 0.04 | -0.12 | -0.19 | -0.23 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.00 | -0.12 | -0.19 | -0.23 |
| EBITDA(a) | $-1,565 | $-784 | $-1,149 | $-1,246 | $-1,091 |